http://cxa.marketwatch.com/TSX/en/Market/article.aspx?guid=ht... CALGARY, Nov 18, 2009 /PRNewswire-FirstCall via COMTEX/ -- Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (ONC)(US:ONCY) announced today that it has entered into an underwriting agreement for an offering of 4,250,000 units, each comprised of one common share and 0.4 of a common share purchase warrant, at a price of US$3.00 per unit to raise gross proceeds of US$12,750,000. Each whole common share purchase warrant entitles the holder to acquire one common share of Oncolytics upon payment of US$3.50, exercisable for a five year period commencing on the closing date of the offering, subject to an acceleration of the expiry date in certain circumstances. Oppenheimer & Co. Inc. is acting as the sole book-running manager for the offering. Canaccord Adams Inc. and Bloom Burton & Co. are acting as co-managers for the offering. http://cxa.marketwatch.com/tsx/en/market/quote.aspx?symbol=ON... ...The risk is high to make profit over 2,80 $... Y M .
$2.83 (11/19/09)
